Adynxx: Adynxx Reports Second Quarter 2019 Financial Results

(marketscreener.com) SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, today announced financial results and provided a business update...http://www.marketscreener.com/ADYNXX-INC-58002353/news/Adynxx-Reports-Second-Quarter-2019-Financial-Results-29063507/?utm_medium=RSS&utm_content=20190814